Alberta Investment Management Corp purchased a new position in shares of Innophos Holdings, Inc. (NASDAQ:IPHS) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 15,200 shares of the specialty chemicals company’s stock, valued at approximately $486,000. Alberta Investment Management Corp owned about 0.08% of Innophos as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Tower Research Capital LLC TRC boosted its stake in shares of Innophos by 471.9% during the 3rd quarter. Tower Research Capital LLC TRC now owns 1,384 shares of the specialty chemicals company’s stock worth $45,000 after acquiring an additional 1,142 shares during the period. Stifel Financial Corp bought a new stake in Innophos in the 3rd quarter valued at $252,000. Millennium Management LLC lifted its holdings in Innophos by 69.9% during the 3rd quarter. Millennium Management LLC now owns 83,852 shares of the specialty chemicals company’s stock valued at $2,721,000 after purchasing an additional 34,509 shares during the last quarter. Dalton Greiner Hartman Maher & Co. boosted its position in Innophos by 4.5% during the fourth quarter. Dalton Greiner Hartman Maher & Co. now owns 120,007 shares of the specialty chemicals company’s stock worth $3,838,000 after purchasing an additional 5,166 shares during the period. Finally, State Street Corp boosted its position in Innophos by 2.0% during the third quarter. State Street Corp now owns 610,403 shares of the specialty chemicals company’s stock worth $19,814,000 after purchasing an additional 12,129 shares during the period. 92.47% of the stock is currently owned by hedge funds and other institutional investors.
IPHS has been the subject of a number of research reports. ValuEngine upgraded shares of Innophos from a “sell” rating to a “hold” rating in a research note on Tuesday, February 4th. BidaskClub downgraded shares of Innophos from a “sell” rating to a “strong sell” rating in a research report on Saturday, January 11th. Finally, Zacks Investment Research raised Innophos from a “sell” rating to a “hold” rating in a research report on Wednesday, January 1st.
IPHS stock opened at $31.99 on Monday. Innophos Holdings, Inc. has a fifty-two week low of $23.85 and a fifty-two week high of $37.53. The company has a debt-to-equity ratio of 1.01, a current ratio of 2.94 and a quick ratio of 1.48. The stock has a market capitalization of $629.88 million, a price-to-earnings ratio of 29.90 and a beta of 1.48. The business’s fifty day moving average price is $31.99 and its two-hundred day moving average price is $32.10.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company’s specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Featured Article: What is the definition of a trade war?
Receive News & Ratings for Innophos Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Innophos and related companies with MarketBeat.com’s FREE daily email newsletter.